Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US. The ...

Sanofi is sponsoring the event for the second year in a row, which brings together 1,000 transplant recipients and live donors to compete.

Ben Whitehouse, head of Rare Diseases, Sanofi UK and Ireland, stated: “At Sanofi, we’re committed to creating fulfilling futures for extraordinary people. No matter how rare their condition.

Sustainable change requires improved study design, market incentives, and patient involvement, write Kate Womersley and colleagues For too long, medical research has defaulted to male physiology, ...

Providing news, analysis, and insights on the Washington, D.C. legal community, including in-depth coverage of SCOTUS, appellate courts, and key regulatory bodies.

Get share market today's live news updates, stock news, sensex news, nifty news, global stock market news, other stock market news today at Indiainfoline.com ...